In The News
BHP, Rio Tinto face sex discrimination, harassment class actions
High Court ends Commonwealth’s quest for $325M over generic Plavix ban
Employers can be on hook for psychiatric injury damages: High Court
Law firms to join forces in class actions against Coles, Woolworths
Funder’s cut in NT stolen wages class action should be capped, court told
Lawyer for Super Retail execs questioned by judge on settlement silence
‘We will hold them to account’: ASIC accuses Rex of misleading market
Full Court overturns defamation win for Jarred Hayne supporter
Telstra pays $3M penalty over Triple Zero outage
In latest class action loss, Bayer defeats case over Essure device
Please login to bookmarkClose

A judge has found Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au